Tue . 19 Jun 2019

Oleandomycin

oleandomycin biosynthesis, oleandomycin
Oleandomycin is a macrolide antibiotic It is synthesized from strains of Streptomyces antibioticus It is weaker than erythromycin

It used to be sold under the brand name Sigmamycine, combined with tetracycline, and made by the company Rosa-Phytopharma in France

Contents

  • 1 Medical Use and Availability
    • 11 Brand names
  • 2 History
    • 21 Origins
    • 22 Combination Drug Sigmamycine
  • 3 Pharmacology
    • 31 Mechanism of Action
    • 32 Relative Strength
  • 4 Chemistry
    • 41 Polyketide synthesis
    • 42 Post-PKS Tailoring
  • 5 References

Medical Use and Availability

Oleandomycin can be employed to inhibit the activities of bacteria responsible for causing infections in the upper respiratory tract much like Erythromycin can Both can affect staphylococcus and enterococcus genera

The MIC for Oleandomycin is 03-3 µg/ml for Staphylococcus Aureus

Oleandomycin is approved as a veterinary antibiotic in some countries It has been approved as a swine and poultry antibiotic in the United States However, it is currently only approved in the United States for production uses

Brand names

  • Mastalone – Oleandomycin, oxatetracycline, neomycin – Zoetis Australia and Pfizer Animal Health
  • Mastiguard – Oleandomycin, oxatetracycline – Stockguard Animal Health
  • Formerly sold as Sigmamycine by Pfizer Oleandomycin + Tetracycline + Vitamin C

History

Origins

Oleandomycin was first discovered as a product of the bacterium Streptomyces Antibioticus in 1954 by Dr Sobin, English, and Celmer In 1960, Hochstein successfully managed to determine the structure of oleandomycin This macrolide was discovered at around the same time as its relatives erythromycin and spiramycin

Combination Drug Sigmamycine

Public interest in oleandomycin peaked when Pfizer introduced the combination drug Sigmamycine into the market in 1956 Sigmamycine was a combination drug of oleandomycin and tetracycline that was supported by a major marketing campaign It was in fact claimed that a 2:1 mixture of tetracycline and oleandomycin had a synergistic effect on staphylococci It was also claimed that the mixture would be effective on organisms that are mostly resistant to tetracycline or oleandomycin alone Both of these claims were refuted by findings such as those by Lawrence P Garrod that could find no evidence that such claims were properly substantiated By the early 1970s, Pfizer’s combination drugs were withdrawn from the market

Pharmacology

Mechanism of Action

Oleandomycin is a bacteriostatic agent Like erythromycin, oleandomycin binds to the 50s subunit of bacterial ribosomes, inhibiting the completion of proteins vital to survival and replication It interferes with translational activity but also with 50s subunit formation

However, unlike erythromycin and its effective synthetic derivatives, it lacks a 12-hydroxyl group and a 3-methoxy group This change in structure may adversely affect its interactions with 50S structures and explain why it is a less powerful antibiotic

Relative Strength

Oleandomycin is far less effective than erythromycin in bacterial minimum inhibitory concentration tests involving staphylococci or enterococci However, macrolide antibiotics can accumulate in organs or cells and this effect can prolong the bioactivity of this category of antibiotics even if its concentration in plasma is below what is considered capable of a therapeutic effect

Chemistry

Polyketide synthesis

See also: Polyketide synthase Polyketide Synthase Type I scheme of the synthesis of 8,8 deoxyoleanolide, the precursor to oleandomycin

The oleandomycin synthase OLES follows the module structure of a type I synthase The polyketide chain is bound through thioester linkages to the S-H groups of the ACP and KS domains not shown

  • The gene cluster OLES1 codes for modules 0-2, module 0 containing an acetyl-CoA starter unit and all remaining moduless carrying a methyl malonyl-CoA elongation unit attached to its keto synthase unit
  • OLES2 codes for modules 3 and 4 Module 3 is notable for potentially carrying a redox-inactive ketoreductase that is responsible for retaining the unreduced carbonyl adjacent to carbon 8
  • OLES3 codes for modules 5 and 6

The amino acid sequence similarities between OLES and 6-Deoxyerythronolide B synthase erythromycin precursor synthase show only a 45% common identity Note that unlike in the erythromycin precursor synthase, there is a KS in the loading domain of OLES

Post-PKS Tailoring

Post-polyketide tailoring of 8,8' deoxyoleanolide to form oleandomycin

The genes OleG1 and G2 are responsible for the glycosyltransferases that attach oleandomycin’s characteristic sugars to the macrolide These sugars are derived from TDP-glucose OLEG1 transfers dTDP-D-desoamine and OleG2 transfers D-TDP-L-oleandrose to the macrolide ring The epoxidation that occurs afterwards is from the enzyme encoded by OleP, which could be homologous with a P450 enzyme The method by which OleP epoxidates is suspected to be a dihydroxylation followed by the conversion of a hydroxyl group into a phosphate group that then leaves via a nucleophilic ring closure by the other hydroxyl group

References

  1. ^ a b Semenitz, E 23 Nov 1977 "The antibacterial activity of oleandomycin and erythromycin—a comparative investigation using microcalorimetry and MIC determination" J Antimicrob Chemother Academic Press Inc 4 5: 455–457 doi:101093/jac/45455 Retrieved 7 May 2016 
  2. ^ "Drugs Transitioning from Over‐the‐Counter OTC to Veterinary Feed Directive VFD Status" PDF US Food and Drug Administration 19 Jan 2016 Retrieved 11 May 2016 
  3. ^ "21 CFR 558435 - Oleandomycin" Legal Information Institute Cornell University Law School 17 Sep 2001 Retrieved 11 May 2016 
  4. ^ "Oleandomycin" Drugscom 16 April 2010 Retrieved 11 May 2016 
  5. ^ a b Garrod, Lawrence P 13 July 1957 "The Erythromycin Group of Antibiotics" British Medical Journal BMJ 2 5036: 57–63 doi:101136/bmj2503657 JSTOR 25383104 
  6. ^ Greene, Jeremy; Podolsky, Scott August 2011 "Combination Drugs- Hype, Harm, Hope" New England Journal of Medicine NEJM group Retrieved 4 May 2016 
  7. ^ Jones Jr, Wilfred f; Finland, Maxwell September 19, 1957 "Antibiotic Combinations — Tetracycline, Erythromycin, Oleandomycin and Spiramycin and Combinations of Tetracycline with Each of the Other Three Agents — Comparisons of Activity in Vitro and Antibacterial Action of Blood after Oral Administration" New England Journal of Medicine NEJM group Retrieved 6 May 2016 
  8. ^ Pfizer Inc v L Richardson c, 434 vF2D 536, 8 United State Court of Appeals, Second Circuit 2 Nov 1970
  9. ^ Champney, W Scott; Tober, Craig L Dec 1998 "A Comparison of the Inhibition of Translation and 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells by Nine Different Macrolide Antibiotics" Current Microbiology Springer-verlag 37 6: 412–417 doi:101007/s002849900402 Retrieved 13 May 2016 
  10. ^ a b Rawlings, Bernard J 4 Jan 2001 "Type I Polyketide Synthesis in Bacteria part B" Natural Products Reports 18: 231–281 doi:101039/b100191o Retrieved 4 May 2016 

oleandomycin, oleandomycin biosynthesis, oleandomycin sigma, oleandomycin triacetate


Oleandomycin Information about

Oleandomycin


  • user icon

    Oleandomycin beatiful post thanks!

    29.10.2014


Oleandomycin
Oleandomycin
Oleandomycin viewing the topic.
Oleandomycin what, Oleandomycin who, Oleandomycin explanation

There are excerpts from wikipedia on this article and video

Random Posts

La Porte, Indiana

La Porte, Indiana

La Porte French for "The Door" is a city in LaPorte County, Indiana, United States, of which it is t...
Fernando Montes de Oca Fencing Hall

Fernando Montes de Oca Fencing Hall

The Fernando Montes de Oca Fencing Hall is an indoor sports venue located in the Magdalena Mixhuca S...
My Everything (The Grace song)

My Everything (The Grace song)

"My Everything" was Grace's 3rd single under the SM Entertainment, released on November 6, 2006 Unli...
Turkish Straits

Turkish Straits

The Turkish Straits Turkish: Türk Boğazları are a series of internationally significant waterways in...